FDA to Authorize Pfizer Vaccine for 12-15 Year-Olds by Next Week: NYT

The Food and Drug Administration is set to authorize the use of the Pfizer-BioNTech COVID-19 vaccine for adolescents aged 12-15 years old as early as next week, The New York Times reported Monday.

Following FDA authorization, an advisory panel from the Centers for Disease Control and Prevention will review data and results from clinical trials to draft recommendations on the use of the vaccine for those 12-15 years old, according to The Times report.

Pfizer announced in late March that their vaccine was highly effective in a trial of more than 2,000 adolescents, and the vaccine was “well tolerated” among those ages 12 to 15.

This story is breaking. Check back for updates.

LoadingSomething is loading.

Source link


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button